Merck is forking out $5.85 per share for the California company, a sizeable premium on Immune Design’s share price of around $1.50 in the weeks building up to the deal, and which values it at ...

Enjoy live support and instant downloads after purchase. The Wix Logo Maker is an AI-powered online logo design tool that enables users to create professional-looking logos quickly and easily.

You’ll get the lockscreen bug on Android 16 Beta 3.1 more often with default clock layout. It’s not clear if this affects more layouts or themes; the only solution we’ve found so far is to ...

It’s not HBO, it’s Max — but the new standalone logo for Warner Bros ... ditching its shiny blue user interface for a new monochrome color palette that, either purposefully or not, evokes ...

Watch The Real Housewives of Atlanta Sundays 8/7c on Bravo and streaming next day on Peacock. “I’m gonna be honest: What I think is [Porsha and Shamea] had some issues during the season ...

The logo evolution signifies Kia's ambition to establish itself as a global automotive leader. Despite its modern design, the new logo has faced criticism for legibility issues. Kia’s branding journey ...

MLB Opening Day 2025 is here as the Baltimore Orioles travel to play the Toronto Blue Jays on Thursday. Last season, the Orioles went 91-71 and made it to the playoffs. Meanwhile, Toronto logged a ...

The Blue Jays selected Straw's contract from Triple-A Buffalo on Thursday, Keegan Matheson of MLB.com reports. After being acquired from the Guardians in January, Straw was able to secure a spot ...

Merck (MRK) released phase III data for an injection form of its blockbuster cancer treatment drug Keytruda and announced the FDA is reviewing the application for approval. The data showed that ...

If you buy through a BGR link, we may earn an affiliate commission, helping support our expert product labs. Apple is widely expected to give iOS 19 a massive design overhaul at WWDC 2025 after ...

A Merck logo is shown on a scientist's lab coat. The Food and Drug Administration, on Sept. 4, 2014, granted accelerated approval to Merck's Keytruda for treating melanoma that has spread or can't be ...